Diseases, Conditions, Syndromes

Hepatitis C: A novel point-of-care assay

One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus (HCV) is the diagnosis of chronic cases that are generally asymptomatic. Major progress is required for new diagnostic techniques ...

Diseases, Conditions, Syndromes

Hepatitis C virus screening rates remain low among baby boomers

Despite the steady increase of liver cancer incidence in the United States in recent decades, data from 2015 indicates that less than 13 percent of individuals born between 1945 and 1965 are estimated to have undergone screening ...

Diseases, Conditions, Syndromes

Icelandic program seeks to eliminate HCV

A new Journal of Internal Medicine study describes an innovative program to eliminate hepatitis C virus (HCV) as a public health threat in Iceland.

Diseases, Conditions, Syndromes

Glecaprevir-pibrentasvir effective treatment for HCV genotypes 1, 3

(HealthDay)—Once-daily treatment with glecaprevir-pibrentasvir appears safe and effective for the treatment of hepatitis C virus (HCV) genotype 1 or 3, according to a study published in the Jan. 25 issue of the New England ...

Diseases, Conditions, Syndromes

Patient's psoriasis improves with initiation of hepatitis C therapy

Researchers report the first case of a patient whose psoriasis improved when therapy for his hepatitis C virus (HCV) infection was initiated. Findings from a brief case report are published in Annals of Internal Medicine.

Diseases, Conditions, Syndromes

Dibenzoazepine found to be effective against resistant hepatitis C

Hepatitis C is caused by a highly infectious virus affecting millions across the globe and can lead to a variety of liver ailments. While the hepatitis C virus (HCV) can sometimes be fought off and cleared by the immune system ...

page 11 from 30